Emerging therapies, AI, and patient-centered approaches are reshaping cardiovascular pharmacy.
Kristen Campbell, PharmD, BCPS, CPP, FACC
Advertisement
Articles by Kristen Campbell, PharmD, BCPS, CPP, FACC
Artificial intelligence is emerging as a vital tool for pharmacists in cardiovascular care—supporting clinical decisions, patient education, and adherence while maintaining guideline alignment.
Despite persistent gaps in cardiovascular risk management, pharmacists are proving essential in improving LDL control, guiding statin use, and supporting evidence-based care across clinical settings.
Pharmacists have become central to titration, access, patient education, and logistics as GLP-1 use grows and cardiometabolic management evolves.
Experts discuss guideline adoption, therapeutic advances, and team-based care.
Experts Craig Beavers and Kristen Campbell discuss what pharmacists should know heading into ACC 26.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Medicare's New GLP-1 Bridge Program: What Pharmacists Need to Know Before Dispensing
2
FDA Approves Ennumo, Pegfilgrastim Biosimilar Referencing Neulasta, for Febrile Neutropenia and Radiation Exposure
3
Single-Shot Respiratory Vaccine Could Transform Pharmacist Counseling and Immunization Rates
4
FDA Expands Wilate Approval for Routine Prophylaxis in Children Younger Than 6 With von Willebrand Disease
5